OTR Therapeutics may still be keeping its own pipeline under wraps, but Zealand Pharma has seen enough promise in the Chinese ...

Existing IPF treatments, including Boehringer’s recently approved Jascayd, slow disease progress rather than halt or reverse ...

The FDA has approved its first at-home, nondrug therapy for depression, a wearable brain stimulation headset developed by Flow Neuroscience.  | The FDA issued a green light that covers the wearable's ...

Formation Bio is inking a deal worth more than $600 million in biobucks for ex-China rights to a next-gen immunology asset ...

Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. | Rival ...

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...

Two affiliates of Apple Tree Partners have filed for bankruptcy, a move designed to continue funding the venture firm's portfolio biotechs as a funding dispute with a top investor plays out. | Two ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...

People come to Orlando to escape. With Disney World, SeaWorld and Universal Studios all in the area, there are endless ...

Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and ...

GSK is officially cutting ties with Ideaya Biosciences, handing back two clinical programs as part of the termination of a ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...